Chronic Cerebral Hypoperfusion

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chronic Cerebral Hypoperfusion trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05072483

Natural History Study of CADASIL

Background: CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy) is a genetic disorder. It causes narrowing of t…

United States155 participantsStarted 2022-04-18

Treatment: MRI

All recent trials (4 shown)

CompletedNot Applicable

NCT02821780

CADASIL Disease Discovery

Cerebral autosomal dominant arteriopathy with subcortical infarct (CADASIL) is a lethal disease caused by a gene mutation that affects arteries in the brain. Sy…

United States20 participantsStarted 2016-10-18

By InvitationNot Applicable

NCT06477107

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

This study is being done to examine whether transcranial direct current stimulation (tDCS) will increase cerebral blood flow which may provide a clinical benefi…

United States50 participantsStarted 2024-10-24

Treatment: Soterix® 4x1HD-TDCS, Soterix® 1x1 tDCS

Chronic Cerebral Hypoperfusion

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Natural History Study of CADASIL

All recent trials (4 shown)

CADASIL Disease Discovery

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Natural History Study of CADASIL

All recent trials (4 shown)

CADASIL Disease Discovery

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

Exploratory Study of Intermittent Hypoxia Treatment in Chronic Cerebral Hypoperfusion